ArticleThe Lancet. Neurology2019
A global perspective on the burden of multiple sclerosis.
Article in The Lancet. Neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06502015 (Biomarkers of Neurological Autoimmune Diseases), which is not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Biomarkers of Neurological Autoimmune Diseases
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Mobile App Interventions for Parkinson's Disease, Multiple Sclerosis and Stroke: A Systematic Literature Review.Sensors (Basel, Switzerland) · 2023Pooled it
- Development of a self-management journey map for people with multiple sclerosis: a qualitative study.BMC neurology · 2026Article
- Effect of Foot Reflexology on Restless Legs Syndrome and Sleep Quality in Female Patients With Multiple Sclerosis: A Randomized, Double-Blind Clinical Trial.Neurology research international · 2026Article
- Preparation, characterisation, and testing of reservoir-based implantable devices loaded with tizanidine and lidocaine.Drug delivery and translational research · 2025Article
- Neural networks to estimate multiple sclerosis disability and predict progression using routinely collected healthcare data.Multiple sclerosis (Houndmills, Basingstoke, England) · 2025Article
- Impact of Contextual Factors on the Perceived Participation of People With Multiple Sclerosis and Gait Impairment Using Mobility Assistive Devices: A Qualitative Analysis.Health expectations : an international journal of public participation in health care and health policy · 2024Article
- Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis.Journal of neurology · 2024Article
- Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.Neurology · 2024Article
- Treatment satisfaction with disease-modifying therapy is the only predictor of Adherence among multiple sclerosis patients from Upper Egypt.Scientific reports · 2024Article
- Shared Decision-Making in the Treatment of Multiple Sclerosis: Results of a Cross-Sectional, Real-World Survey in Europe and the United States.Patient preference and adherence · 2024Article
- Evaluation of obsessive-compulsive disorder prevalence in Iranian patients with multiple sclerosis and its relationship with demographic characteristics.Current journal of neurology · 2023Article
- Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges.Journal of clinical medicine · 2023Review
- Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients.Scientific reports · 2023Article
- Application value of plasma Neurofilament light combined with magnetic resonance imaging to comprehensively evaluate multiple sclerosis activity and status.Frontiers in neurology · 2023Article
- The role of plasma cortisol in dementia, epilepsy, and multiple sclerosis: A Mendelian randomization study.Frontiers in endocrinology · 2023Article
- ENTIMOS: A Discrete Event Simulation Model for Maximising Efficiency of Infusion Suites in Centres Treating Multiple Sclerosis Patients.Applied health economics and health policy · 2022Article
- Cerebrospinal Fluid α-Calcitonin Gene-Related Peptide: A Comparison between Alzheimer's Disease and Multiple Sclerosis.Biomolecules · 2022Article
- Burden of multiple sclerosis in Iran from 1990 to 2017.BMC neurology · 2021Article
- IFP35 family proteins promote neuroinflammation and multiple sclerosis.Proceedings of the National Academy of Sciences of the United States of America · 2021Article
- Cost-effectiveness of ocrelizumab for treatment of Iranian patients with relapsing multiple sclerosis.Current journal of neurology · 2021Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
30679041What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.